Approach to postpartum fever: Clinical sciences

Last updated: January 30, 2025

Approach to postpartum fever: Clinical sciences

Pregnancy, childbirth, and the puerperium

Pregnancy, childbirth, and the puerperium

Preconception care: Clinical sciences
Antepartum fetal surveillance: Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Maternal D alloimmunization (prevention): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Fetal growth restriction: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Maternal D alloimmunization (management): Clinical sciences
Multifetal gestation: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Induction of labor: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Intrapartum fetal heart rate monitoring: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Pain management during labor: Clinical sciences
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Shoulder dystocia: Clinical sciences
Vaginal birth after cesarean (VBAC): Clinical sciences
Approach to postpartum fever: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Uterine atony: Clinical sciences
Immediate care of the well newborn: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to birth injury (pediatrics): Clinical sciences
Approach to complications of prematurity (early): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to congenital infections: Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Asthma in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Anatomy clinical correlates: Female pelvis and perineum
Chlamydia trachomatis
Neisseria gonorrhoeae
Streptococcus agalactiae (Group B Strep)
Treponema pallidum (Syphilis)
Toxoplasma gondii (Toxoplasmosis)
Cytomegalovirus
Hepatitis B and Hepatitis D virus
Herpes simplex virus
HIV (AIDS)
Influenza virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Congenital TORCH infections: Pathology review
Complications during pregnancy: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants

Decision-Making Tree

Transcript

Watch video only

Postpartum fever is a temperature of 38 degrees Celsius or 100.4 degrees Fahrenheit or more on two occasions at least four to six hours apart, excluding the first 24 hours after birth. Postpartum febrile episodes often resolve without intervention if occurring within the first 24 hours of delivery, and for this reason the threshold for a fever in the first day after delivery is typically set at 39 degrees Celsius or 102.2 degrees Fahrenheit. The source of a maternal postpartum fever varies based on how many days your patient presents after birth, particularly within the first 7 days postpartum.

Now, if your patient presents with a postpartum fever, you should first perform an ABCDE assessment to determine if your patient is unstable or stable. If unstable, stabilize their airway, breathing, and circulation. Next, obtain IV access and start fluid resuscitation, and consider starting broad-spectrum intravenous antibiotics. Place your patient on continuous vital sign monitoring, including blood pressure, heart rate, and oxygen saturation. Finally, if needed, provide supplemental oxygen!

Okay, now let’s go back to the ABCDE assessment and take a look at stable patients. Start by obtaining a focused history and physical examination; then obtain labs including a CBC, urinalysis, and urine culture. Next, review the mode of delivery, and how many days away they are from delivery.

Here’s a clinical pearl! It’s common for patients to have a transient low-grade fever within the first 24 hours postpartum, particularly in patients who delivered vaginally, or who have been treated for an intraamniotic infection. Other factors that might cause a transient postpartum fever include misoprostol use, dehydration, and epidural analgesia. However, if your patient has a temperature greater than 39 degrees Celsius or 102.2 degrees Fahrenheit on the first day after delivery, don’t delay looking for a cause!

First let’s discuss conditions which can present within the first 1 to 3 days postpartum, starting with endometritis. Your patient will typically present with malaise and lower midline abdominal cramping and pain. Additionally, they may have more uterine bleeding than expected. Your patient may also have certain risk factors like a positive group B streptococcus, or GBS, status; prolonged labor or prolonged ruptured membranes; or an intraamniotic infection during labor. Additional risk factors include interventions during delivery, such as a C-section; an operative vaginal delivery, like using forceps or a vacuum extractor to assist with the delivery; or manual removal of the placenta.

On physical examination, vital signs may demonstrate tachycardia, and your patient will usually have a tender uterine fundus. You may also detect a foul-smelling or purulent lochia. Labs will show an elevated white blood cell, or WBC count, possibly with a left-shift and an upward trend of neutrophils. Urinalysis and urine culture will be normal. With these findings, diagnose postpartum endometritis.

Time for another clinical pearl! WBC counts will normally increase during labor, and can get as high as 30,000 cells per microliter in the first 24 hours postpartum. It may take up to a week for the WBC count to return to normal, so be cautious when interpreting the presence of leukocytosis in a patient with postpartum fever, especially during the first week.

Now let’s move on to pyelonephritis. Your patient will typically report dysuria as well as urinary frequency and urgency. They may also report suprapubic pain, flank pain, and hematuria.

On physical examination you may find suprapubic tenderness as well as unilateral costovertebral angle, or CVA tenderness. The CBC may show an elevated WBC count, possibly with a left-shift; and urinalysis will typically be positive for nitrites and pyuria. Finally, urine culture will demonstrate greater than 100,000 colony forming units of bacteria per milliliter. In this case, your diagnosis is pyelonephritis.

Now let’s focus on those who experience fever 3 to 5 days postpartum. A significant cause of fever in this time frame is surgical site infection, which could occur following a C-section, but could occur in those who had either a significant vaginal laceration or an episiotomy. Patients will report peri-incisional pain, and purulent discharge with a foul odor.

Your patient’s history may also include risk factors like prolonged labor or an intraamniotic infection, which may seed the incisional site and subcutaneous tissue layers at the time of delivery. There may also be additional risk factors for infection and poor wound healing, including obesity and poorly controlled diabetes mellitus.

On physical examination, you may detect erythema, warmth, purulent discharge, and swelling at the surgical or laceration site. If your patient’s abdominal incision is infected, remember to explore their wound to look for the presence of a fascial dehiscence.

Laboratory evaluation will show an elevated WBC count with a possible left-shift. The urinalysis and urine culture will be negative. With these findings, diagnose a surgical site infection.

Here’s another clinical pearl! Patients with a surgical site infection should have a culture and Gram stain of the interior of the wound, taking care not to sample the surrounding skin. This ensures appropriate antibiotic therapy, particularly in the setting of methicillin-resistant staphylococcus aureus, or MRSA; or other drug-resistant pathogens. Additionally, if your patient develops systemic symptoms, be sure to collect blood cultures to rule out septicemia.

Sources

  1. "ACOG Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection" Obstet Gynecol (2017)
  2. "ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy" Obstet Gynecol (2018)
  3. "ACOG Practice Bulletin No. 199 Summary: Use of Prophylactic Antibiotics in Labor and Delivery" Obstet Gynecol (2019)
  4. "Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017" JAMA Surg (2017)
  5. "Guidelines for perinatal care, 8th ed" American Academy of Pediatrics Committee on Fetus and Newborn & American College of Obstetricians and Gynecologists Committee on Obstetric Practice (2017)
  6. "Postpartum Infection" StatPearls [Internet] (2023)
  7. "Surgical site infection following cesarean deliveries: trends and risk factors" J Matern Fetal Neonatal Med (2017)